Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-23

Clinical Trial Update: Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia

View source ↗

Summary

This completed clinical trial update analyzes prescribing patterns and patient adherence to iron chelation therapy in individuals with thalassemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)
  • Deferiprone (deferiprone)
  • Deferoxamine (deferoxamine)

Snippet

Sponsor: Reem Ali Shaker | Conditions: Thalassemia | Status: COMPLETED